Found: 13
Select item for more details and to access through your institution.
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.
- Published in:
- Nature Medicine, 2008, v. 14, n. 12, p. 1351, doi. 10.1038/nm.1890
- By:
- Publication type:
- Article
PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 9, p. 967
- By:
- Publication type:
- Article
Comparative study of the p53-mdm2 and p53-MDMX interfaces.
- Published in:
- Oncogene, 1999, v. 18, n. 1, p. 189, doi. 10.1038/sj.onc.1202281
- By:
- Publication type:
- Article
Study of the cytotoxic effect of a peptidic inhibitor of the p53–hdm2 interaction in tumor cells
- Published in:
- FEBS Letters, 2002, v. 529, n. 2/3, p. 293, doi. 10.1016/S0014-5793(02)03362-8
- By:
- Publication type:
- Article
FGFR2 Promotes Breast Tumorigenicity through Maintenance of Breast Tumor-Initiating Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0051671
- By:
- Publication type:
- Article
Who's Who in Chemical Biology & Drug Design.
- Published in:
- 2006
- By:
- Publication type:
- Other
A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.
- Published in:
- Nature Chemical Biology, 2014, v. 10, n. 12, p. 1013, doi. 10.1038/nchembio.1681
- By:
- Publication type:
- Article
Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 4, p. 337, doi. 10.1111/j.1600-0609.2009.01403.x
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 5, p. 761, doi. 10.2967/jnumed.109.071043
- By:
- Publication type:
- Article
Anti-myeloma activity of the novel 2-aminothienopyrimidine Hsp90 inhibitor NVP-BEP800.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 3, p. 319, doi. 10.1111/j.1365-2141.2009.07852.x
- By:
- Publication type:
- Article
The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 4, p. 470, doi. 10.1111/j.1365-2141.2008.07049.x
- By:
- Publication type:
- Article
ATP site-directed competitive and irreversible inhibitors of protein kinases.
- Published in:
- Medicinal Research Reviews, 2000, v. 20, n. 1, p. 28, doi. 10.1002/(SICI)1098-1128(200001)20:1<28::AID-MED2>3.0.CO;2-2
- By:
- Publication type:
- Article